Palliative Pain Treatment in Patients with Bone Metastasis – A Review
DOI:
https://doi.org/10.12775/QS.2025.39.59070Keywords
bone metastasis, cancer, pain, palliative treatment, chemotherapy, radiotherapy, minimally invasive surgeryAbstract
Finding cancer metastases to the bone in cancer patients significantly worsens their prognosis and transforms them into palliative patients. Unfortunately, as they are diagnosed more frequently, the health problems that result from the appearance of such lesions are becoming more and more common. Fortunately, there are a number of treatments for bone metastases that improve quality of life and prolong patient survival. These include classic methods, such as chemotherapy, radiation therapy, and surgical approaches, but doctors can also offer an increasing number of modern treatments, such as minimally invasive surgical methods and drugs that target bone directly. This article reviews the literature reports of current treatments for bone metastases.
References
1. Macedo F, Ladeira K, Pinho F, Saraiva N, Bonito N, Pinto L, et al. Bone metastases: An overview. Oncol Rev. 2017;11(1).
2. Ryan C, Stoltzfus KC, Horn S, Chen H, Louie A V., Lehrer EJ, et al. Epidemiology of bone metastases. Bone. 2022 May;158:115783.
3. Colosia A, Njue A, Bajwa Z, Dragon E, Robinson RL, Sheffield KM, et al. The Burden of Metastatic Cancer–Induced Bone Pain: A Narrative Review. J Pain Res. 2022 Oct;Volume 15:3399–412.
4. Macedo F, Ladeira K, Pinho F, Saraiva N, Bonito N, Pinto L, et al. Bone metastases: an overview. Oncol Rev. 2017 May 9;
5. Bailey S, Stadelmann MA, Zysset PK, Vashishth D, Alkalay RN. Influence of Metastatic Bone Lesion Type and Tumor Origin on Human Vertebral Bone Architecture, Matrix Quality, and Mechanical Properties. Journal of Bone and Mineral Research. 2020 Dec 1;37(5):896–907.
6. Zajączkowska R, Leppert W, Wordliczek J. Bone pain in cancer patients — what is known about its pathomechanisms? Palliative Medicine in Practice. 2017;11(1):17–23.
7. Nakanishi K, Tanaka J, Nakaya Y, Maeda N, Sakamoto A, Nakayama A, et al. Whole-body MRI: detecting bone metastases from prostate cancer. Vol. 40, Japanese Journal of Radiology. 2022.
8. Middlemiss T, Laird BJA, Fallon MT. Mechanisms of Cancer-induced Bone Pain. Clin Oncol. 2011 Aug;23(6):387–92.
9. Aielli F, Ponzetti M, Rucci N. Bone Metastasis Pain, from the Bench to the Bedside. Int J Mol Sci. 2019 Jan 11;20(2):280.
10. Brjussowa SS, Lebedenko WW. Zur Schmerzleitungsfähigkeit der Gefäße. Z Gesamte Exp Med. 1930 Jan;69(1):29–40.
11. Zhao J, Levy D. The sensory innervation of the calvarial periosteum is nociceptive and contributes to headache-like behavior. Pain. 2014 Jul;155(7):1392–400.
12. Goswami R. Primer on the metabolic bone diseases and disorders of mineral metabolism. Indian Journal of Medical Research. 2016;144(3):489.
13. Colosia A, Njue A, Bajwa Z, Dragon E, Robinson RL, Sheffield KM, et al. The Burden of Metastatic Cancer–Induced Bone Pain: A Narrative Review. J Pain Res. 2022 Oct;Volume 15:3399–412.
14. Morlion B. Pharmacological cancer pain management. Pain Practice [Internet]. 2014;14:8. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L71512403&from=export
15. Gillis JC, Brogden RN. Ketorolac. Drugs. 1997 Jan;53(1):139–88.
16. Gordon RL. Prolonged Central Intravenous Ketorolac Continuous Infusion in a Cancer Patient with Intractable Bone Pain. Annals of Pharmacotherapy. 1998 Feb 26;32(2):193–6.
17. Nakanishi H, Nagasawa K. Treatment with Continuous Infusion of Fentanyl and Long-term Intracolostomal Administration of Diclofenac Suppositories Effective for Cancer Pain Stemming from Postoperative Bone Metastasis of Rectal Cancer. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 2006;32(6):576–80.
18. Liu Z, Xu Y, Liu Z liang, Tian Y zhou, Shen X heng. Combined application of diclofenac and celecoxib with an opioid yields superior efficacy in metastatic bone cancer pain: a randomized controlled trial. Int J Clin Oncol. 2017 Oct 8;22(5):980–5.
19. Chapman EJ, Edwards Z, Boland JW, Maddocks M, Fettes L, Malia C, et al. Practice review: Evidence-based and effective management of pain in patients with advanced cancer. Palliat Med. 2020 Apr 24;34(4):444–53.
20. Yoshida M, Iwasaki K, Miyashita M, Saeki T, Morioka Y, Hiroi S, et al. Opioid prescriptions at the point of surgery, bone metastasis, or death among patients with breast cancer in Japanese acute care hospitals: a claims-based, retrospective, longitudinal study. Supportive Care in Cancer. 2023 Jun 2;31(6):369.
21. Zhang H, Paice J, Portenoy R, Bruera E, Reid MC, Bao Y. Prescription Opioids Dispensed to Patients with Cancer with Bone Metastasis: 2011–2017. Oncologist. 2021 Oct 1;26(10):e1890–2.
22. Pergolizzi J V., Raffa RB, Rosenblatt MH. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management. J Clin Pharm Ther. 2020 Oct 27;45(5):892–903.
23. Portenoy RK. Treatment of cancer pain. The Lancet. 2011 Jun;377(9784):2236–47.
24. Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012 Feb;13(2):e58–68.
25. Schneider G, Voltz R, Gaertner J. Cancer Pain Management and Bone Metastases: An Update for the Clinician. Breast Care. 2012;7(2):113–20.
26. Zaporowska-Stachowiak I, Adannia Oduah MT, Cielichowska M, Dziuba G, Mikołajczak A, Perlińska M, et al. Opioidy w praktyce klinicznej. Varia Medica. 2020;4(1):43–51.
27. Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an international expert panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Practice. 2008;8(4):287–313.
28. Leppert W. Pain management in patients with cancer: Focus on opioid analgesics. Curr Pain Headache Rep. 2011 Aug;15(4):271–9.
29. Spiegel R, Rothschild SI, Sutter R, Kalla R. Painkiller-related dizziness in malignant tumors: A systematic review. Annals of Oncology. 2018 Oct;29:viii636.
30. Michael N, Sulistio M, Wojnar R, Gorelik A. Methadone rotation versus other opioid rotation for refractory cancer induced bone pain: protocol of an exploratory randomised controlled open-label study. BMC Palliat Care. 2023 Apr 15;22(1):42.
31. Sulistio M, Wojnar R, Key S, Kwok J, Al-Rubaie Z, Michael N. The role of methadone in cancer-induced bone pain: a retrospective cohort study. Supportive Care in Cancer. 2021 Mar 6;29(3):1327–35.
32. Yozefovich P. Cancer Pain Relief for Patients with Bone Metastases; Methods and Clinical Practice Literature review. [Kaunas]: Lithuanian University of Health Sciences; 2023.
33. Malec-Milewska M. Adiuwanty (koanalgetyki) w leczeniu bólu u chorego na nowotwór. Onkologia po Dyplomie. 2016;13(6).
34. Woroń J, Adamczyk A, Malec-Milewska M, Jakowicka-Wordliczek J. Stosowanie koanalgetyków u pacjentów z bólem neuropatycznym w przebiegu choroby nowotworowej. Palliative Medicine in Practice. 2014;8(2):85–90.
35. Zajączkowska R, Kocot-Kępska M, Leppert W, Wordliczek J. Bone Pain in Cancer Patients: Mechanisms and Current Treatment. Int J Mol Sci. 2019 Nov 30;20(23):6047.
36. Ikeuchi M. Combinations of Low-Dose Antidepressants and Low-Dose Pregabalin as Useful Adjuvants to Opioids for Intractable, Painful Bone Metastases. Pain Physician. 2014 Sep 14;5;16(5;9):E547–52.
37. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain. 2010 Sep;150(3):573–81.
38. Brozović G. Cancer Pain and Therapy. Acta Clin Croat. 2022;
39. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, Gabapentin, or Their Combination for Neuropathic Pain. New England Journal of Medicine. 2005 Mar 31;352(13):1324–34.
40. Keskinbora K, Pekel AF, Aydinli I. Gabapentin and an Opioid Combination Versus Opioid Alone for the Management of Neuropathic Cancer Pain: A Randomized Open Trial. J Pain Symptom Manage. 2007 Aug;34(2):183–9.
41. Saito O, Aoe T, Kozikowski A, Sarva J, Neale JH, Yamamoto T. Regional Anesthesia and Pain. Canadian Journal of Anesthesia/Journal canadien d’anesthésie. 2006 Sep;53(9):891–8.
42. Grande LA, O’Donnell BR, Fitzgibbon DR, Terman GW. Ultra-Low Dose Ketamine and Memantine Treatment for Pain in an Opioid-Tolerant Oncology Patient. Anesth Analg. 2008 Oct;107(4):1380–3.
43. Lussier D, Huskey AG, Portenoy RK. Adjuvant Analgesics in Cancer Pain Management. Oncologist. 2004 Sep 1;9(5):571–91.
44. Haywood A, Good P, Khan S, Leupp A, Jenkins-Marsh S, Rickett K, et al. Corticosteroids for the management of cancer-related pain in adults. Cochrane Database of Systematic Reviews. 2015 Apr 24;2021(1).
45. Tzschentke TM. Pharmacology of bisphosphonates in pain. Br J Pharmacol. 2021 May 11;178(9):1973–94.
46. WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. In Geneva: World Health Organization; 2018.
47. Patrick DL, Cleeland CS, von Moos R, Fallowfield L, Wei R, Öhrling K, et al. Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents. Supportive Care in Cancer. 2015 Apr 23;23(4):1157–68.
48. Yayan J. Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the Bone: A Systematic Review and Meta-Analysis. Cancer Control. 2020;27(3).
49. Porta-Sales J, Garzón-Rodríguez C, Llorens-Torromé S, Brunelli C, Pigni A, Caraceni A. Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project. Palliat Med. 2017 Jan 10;31(1):5–25.
50. Vital CG, Maranhão RC, Freitas FR, Van Eyll BM, Graziani SR. Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: Lack of toxicity and therapeutic benefits. J Bone Oncol. 2022 Jun 1;34.
51. Vakaet LAML, Boterberg T. Pain control by ionizing radiation of bone metastasis. Vol. 48, International Journal of Developmental Biology. 2004. p. 599–606.
52. De Felice F, Piccioli A, Musio D, Tombolini V. The role of radiation therapy in bone metastases management. Vol. 8, Oncotarget. Impact Journals LLC; 2017. p. 25691–9.
53. Kubota H, Soejima T, Sulaiman NS, Sekii S, Matsumoto Y, Ota Y, et al. Predicting the survival of patients with bone metastases treated with radiation therapy: A validation study of the Katagiri scoring system. Radiation Oncology. 2019 Jan 18;14(1).
54. Cheon PM, Wong E, Thavarajah N, Dennis K, Lutz S, Zeng L, et al. A definition of “uncomplicated bone metastases” based on previous bone metastases radiation trials comparing single-fraction and multi-fraction radiation therapy. J Bone Oncol. 2015 Mar 1;4(1):13–7.
55. Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. The Lancet. 2005 Aug;366(9486):643–8.
56. Townsend PW, Smalley SR, Cozad SC, Rosenthal HG, Hassanein RES. Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease. International Journal of Radiation Oncology*Biology*Physics. 1995 Jan;31(1):43–9.
57. Cole JS, Patchell RA. Metastatic epidural spinal cord compression. Lancet Neurol. 2008 May;7(5):459–66.
58. Oldenburger E, Brown S, Willmann J, van der Velden JM, Spałek M, van der Linden YM, et al. ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases. Radiotherapy and Oncology. 2022 Aug;173:240–53.
59. Kluska A, Tomasik B, Osadnik A, Tracz N, Trąbska Kluch B, Matysiak P, et al. Retrospective analysis of the effectiveness of volumetric modulated arc therapy half body irradiation in palliation of pain in patients with multiple bone metastases. Mol Clin Oncol. 2022 Sep 21;17(5):153.
60. Macchia G, Ferro M, Cilla S, Buwenge M, Ianiro A, Boccardi M, et al. Efficacy and safety of 3D-conformal half body irradiation in patients with multiple bone metastases. Clin Exp Metastasis. 2018 Dec 24;35(8):747–52.
61. Ito K, Yamaguchi T, Ogawa H, Nakajima Y, Karasawa K. Stereotactic body radiotherapy for bone metastases in patients with colorectal cancer. Jpn J Clin Oncol. 2020 Dec 16;50(12):1442–6.
62. Burgess L, Nguyen E, Tseng CL, Guckenberger M, Lo SS, Zhang B, et al. Practice and principles of stereotactic body radiation therapy for spine and non-spine bone metastases. Clin Transl Radiat Oncol. 2024 Mar;45:100716.
63. Spencer KL, van der Velden JM, Wong E, Seravalli E, Sahgal A, Chow E, et al. Systematic Review of the Role of Stereotactic Radiotherapy for Bone Metastases. JNCI: Journal of the National Cancer Institute. 2019 Oct 1;111(10):1023–32.
64. Ito K, Nakajima Y, Ogawa H, Taguchi K. Fracture risk following stereotactic body radiotherapy for long bone metastases. Jpn J Clin Oncol. 2022 Jan 3;52(1):47–52.
65. Olson R, Schlijper R, Chng N, Matthews Q, Arimare M, Mathews L, et al. SUPR-3D: A randomized phase iii trial comparing simple unplanned palliative radiotherapy versus 3d conformal radiotherapy for patients with bone metastases: study protocol. BMC Cancer. 2019 Dec 28;19(1):1011.
66. Ignat P, Todor N, Ignat RM, Șuteu O. Prognostic Factors Influencing Survival and a Treatment Pattern Analysis of Conventional Palliative Radiotherapy for Patients with Bone Metastases. Current Oncology. 2021 Oct 1;28(5):3876–90.
67. Pope K, Fitzpatrick D, Potter A, Holwell M, Wang L, Lau M, et al. Dosimetric and clinical impact of 3D vs. 2D planning in palliative radiotherapy for bone metastases. Supportive Care in Cancer. 2013 Aug 16;21(8):2229–35.
68. Rief H, Katayama S, Bruckner T, Rieken S, Bostel T, Förster R, et al. High-dose single-fraction IMRT versus fractionated external beam radiotherapy for patients with spinal bone metastases: study protocol for a randomized controlled trial. Trials. 2015 Dec 9;16(1):264.
69. Sprave T, Verma V, Förster R, Schlampp I, Hees K, Bruckner T, et al. Bone density and pain response following intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for vertebral metastases - secondary results of a randomized trial. Radiation Oncology. 2018 Dec 30;13(1):212.
70. Choi JY. Treatment of Bone Metastasis with Bone-Targeting Radiopharmaceuticals. Vol. 52, Nuclear Medicine and Molecular Imaging. Springer Verlag; 2018. p. 200–7.
71. F. G, C. B, J. D, A. S. Radionuclide therapy of bone metastases by bone seeking radiopharmaceutics. Revue du Rhumatisme Monographies [Internet]. 2017;84(2):161–5. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L613245180
72. Ban J, Fock V, Aryee DNT, Kovar H. Mechanisms, Diagnosis and Treatment of Bone Metastases. Cells. 2021 Oct 29;10(11):2944.
73. Tanaka A, Katagiri H, Murata H, Wasa J, Miyagi M, Honda Y, et al. Surgery for femoral metastases. Bone Joint J. 2020 Mar;102-B(3):285–92.
74. Saravana-Bawan S, David E, Sahgal A, Chow E. Palliation of bone metastases—exploring options beyond radiotherapy. Ann Palliat Med. 2019 Apr;8(2):168–77.
75. Jakobs TF, Trumm C, Reiser M, Hoffmann RT. Percutaneous vertebroplasty in tumoral osteolysis. Eur Radiol. 2007 Aug 3;17(8):2166–75.
76. Roedel B, Clarençon F, Touraine S, Cormier E, Molet-Benhamou L, Le Jean L, et al. Has the percutaneous vertebroplasty a role to prevent progression or local recurrence in spinal metastases of breast cancer? Journal of Neuroradiology. 2015 Jul;42(4):222–8.
77. Balestrino A, Boriani S, Cecchinato R, Parafioriti A, Gambarotti M, Gasbarrini A. Vertebroplasty shows no antitumoral effect on vertebral metastasis: a case-based study on anatomopathological examinations. European Spine Journal. 2020 Dec 4;29(12):3157–62.
78. Pretell J, Rodriguez J, Blanco D, Zafra A, Resines C. Treatment of pathological humeral shaft fractures with intramedullary nailing. A retrospective study. Int Orthop. 2010 Apr 2;34(4):559–63.
79. Steensma M, Boland PJ, Morris CD, Athanasian E, Healey JH. Endoprosthetic Treatment is More Durable for Pathologic Proximal Femur Fractures. Clin Orthop Relat Res. 2012 Mar;470(3):920–6.
80. Li C, Wu Q, Chang D, Liang H, Ding X, Lao C, et al. State-of-the-art of minimally invasive treatments of bone metastases. J Bone Oncol. 2022 Jun;34:100425.
81. Filippiadis DK, Tutton S, Kelekis A. Percutaneous bone lesion ablation. Radiol Med. 2014 Jul 4;119(7):462–9.
82. Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update. Radiology. 2014 Oct;273(1):241–60.
83. Mertyna P, Hines-Peralta A, Liu Z jun, Halpern E, Goldberg W, Goldberg SN. Radiofrequency Ablation: Variability in Heat Sensitivity in Tumors and Tissues. Journal of Vascular and Interventional Radiology. 2007 May;18(5):647–54.
84. ter Haar G. Principles of High-Intensity Focused Ultrasound. In: Interventional Oncology. New York, NY: Springer New York; 2012. p. 51–63.
85. Zhou Q, Zhu XQ, Zhang J, Xu ZL, Lu P, Wu F. Changes in Circulating Immunosuppressive Cytokine Levels of Cancer Patients After High Intensity Focused Ultrasound Treatment. Ultrasound Med Biol. 2008 Jan;34(1):81–7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Karolina Mikołajczak, Hanna Ćwirko, Urszula Garlak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 113
Number of citations: 0
